Literature DB >> 5982343

Factors influencing in vitro susceptibility to the cephalosporins and clinical trial of an oral cephalosporin, cephaloglycin.

A R Ronald, M Turck.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5982343

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother (Bethesda)


× No keyword cloud information.
  7 in total

1.  Evaluation of a new cephalosporin antibiotic, cephapirin.

Authors:  P Wiesner; R MacGregor; D Bear; S Berman; K Holmes; M Turck
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

2.  Cephaloglycin and its biologically active metabolite desacetylcephaloglycin.

Authors:  W E Wick; W E Wright; H V Kuder
Journal:  Appl Microbiol       Date:  1971-03

3.  In vitro antimicrobial activity and human pharmacology of cephaloglycin.

Authors:  J M Applestein; E B Crosby; W D Johnson; D Kaye
Journal:  Appl Microbiol       Date:  1968-07

4.  Cephalexin and cephaloglycin activity in vitro and absorption and urinary excretion of single oral doses in normal young adults.

Authors:  P Braun; J R Tillotson; C Wilcox; M Finland
Journal:  Appl Microbiol       Date:  1968-11

5.  Biological properties of three 3-heterocyclic-thiomethyl cephalosporin antibiotics.

Authors:  W E Wick; D A Preston
Journal:  Antimicrob Agents Chemother       Date:  1972-03       Impact factor: 5.191

6.  Regression curve analysis of cephalosporin activity.

Authors:  J A Washington; P K Yu
Journal:  Appl Microbiol       Date:  1970-04

7.  Effect of assay medium on the antibacterial activity of certain penicillins and cephalosporins.

Authors:  T A Pursiano; M Misiek; F Leitner; K E Price
Journal:  Antimicrob Agents Chemother       Date:  1973-01       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.